For patients with opioid use disorder (OUD), evidence supports continuation of buprenorphine during episodes of acute pain, ...
The following is a summary of “Pathways to Growth in Chronic Pain: Understanding Mechanisms of Posttraumatic Growth in Racial ...
In chronic low back pain, botulinum neurotoxin type A improved patients' pain and functional outcomes vs placebo and other local injection therapies.
To tackle childhood pain holistically, architecture is part of the treatment plan at UCSF's pain-focused Stad Center.
There is some evidence that CBD can benefit pain. Read on to learn how effective CBD can be for inflammation, chronic pain ... positive attitudes toward CBD treatment options and report positive ...
Objectives We aimed to estimate the prevalence of chronic bronchitis (CB), examine its association ... Methods A two-phased, cross-sectional design was used to analyse a random sample collected in ...
A novel analysis of more than 375 published studies concluded that the association between chronic pain and rates of depression and anxiety is staggering. The study, led by investigators at Johns ...
Canadian technology stalwart Mitel Networks Corp. has filed for creditor protection, armed with a restructuring plan supported by most of its lenders that will slash its debt and interest costs.
People with severe respiratory diseases, like Chronic Obstructive Pulmonary Disease ... While I also have nebulization treatment, I don’t use it during Ramadan since it’s liquid-based ...
To relieve chronic back pain, medications such as non-steroidal anti-inflammatory drugs (such as ibuprofen) or muscle relaxants help manage symptoms. People who need more advanced treatment may need ...
To address these inconsistencies, the current study aims to more comprehensively examine the relationship between alexithymia and neurocognitive performance in patients with chronic SCZ. By including ...
Eligible patients were at least 18 years of age with chronic spontaneous urticaria diagnosed 6 months or more before screening that remained symptomatic during treatment with second-generation H 1 ...